High materiality7/10
Moderna downgraded to Sell from Neutral at Rothschild & Co Redburn
Why it may matterVerify against the original reporting
sell
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Moderna downgraded to Sell with a target of $81; current price is $150.81.
- Moderna downgraded to Sell; tgt $81 vs price $150.81.
- Bearish setup despite lower target.
Key facts
- 01
Target: $81
- 02
Posted price: $150.81
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.